Comparing High-Intensity Versus Low-to Moderate-Intensity Statin Therapy in Korean Patients with Acute Myocardial Infarction.
- Author:
Minah KIM
1
;
Hyun Kuk KIM
;
Youngkeun AHN
;
Hyukjin PARK
;
Myung Ho JEONG
;
Jeong Gwan CHO
;
Jong Chun PARK
;
Young Jo KIM
;
Myeong Chan CHO
;
Chong Jin KIM
Author Information
- Publication Type:Original Article
- Keywords: Myocardial infarction; Statin; Secondary prevention
- MeSH: Death; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors*; Incidence; Korea; Myocardial Infarction*; Secondary Prevention; Survival Rate
- From:Journal of Lipid and Atherosclerosis 2014;3(2):97-104
- CountryRepublic of Korea
- Language:Korean
- Abstract: OBJECTIVE: The aim of this study is to compare the clinical benefits between high-intensity and low-to moderate-intensity statin therapy in patients with acute myocardial infarction (AMI). METHODS: A total of 1,230 patients in the Korea AMI Registry (KAMIR) were enrolled. Patients were divided into two groups according to the dosage of statin for the secondary prevention after AMI. The primary endpoint was composite of major adverse cardiac events (MACEs) including cardiac death, non-fatal MI, repeat revascularization during the 12 months of clinical follow-up. RESULT: The primary endpoint occurred in 101 patients (11.3%) from the low-to moderate-intensity statin group and 45 patients (13.4%) from the high-intensity statin group. The cumulative incidence of MACEs during 12-month follow-up was not significantly different between the two groups (p=0.323). After multi-variate analysis, MACEs-free survival rate was not significantly different between the two groups. CONCLUSION: High-intensity statin therapy did not show additional clinical benefit over low-to moderate-intensity statin therapy after AMI.
